CIM News Alert Chimera Investment Corp (CIM) 3.28 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Chimera Investment Corp (CIM) 3.28 $CIM

Why Do High-Yield Stocks Like American Realty Capital Bring Out Bad Executive Behavior?
John Maxfield, The Motley Fool - Motley Fool - Sun Dec 21, 1:04PM CST
The ongoing accounting debacle at American Realty Capital is a sordid affair. But far from being an exception to the rule among high-yielding companies such as real estate investment trusts and business development companies, this scandal is only...
NLY: 11.21 (-0.05), CIM: 3.28 (-0.03), PSEC: 8.59 (-0.02)

Chimera Investment announces Q4 dividend of USD0.09 per share
M2 - Fri Dec 19, 5:01AM CST
The board of directors of Chimera Investment Corporation (NYSE:CIM), a real estate investment trust, approved a fourth quarter 2014 cash dividend of USD0.09 per share on the company common stock, it revealed on Friday.
CIM: 3.28 (-0.03)

Chimera Investment declares $0.09 dividend
Seeking Alpha - at Seeking Alpha - Thu Dec 18, 3:48PM CST

CIM: 3.28 (-0.03)

Chimera Investment Corporation Declares 4th Quarter Dividend
Business Wire - Thu Dec 18, 3:46PM CST
The Board of Directors of Chimera today announced the declaration of its fourth quarter 2014 cash dividend of $0.09 per common share. This dividend is payable January 29, 2015, to common shareholders of record on December 31, 2014. The ex-dividend date is December 29, 2014.
CIM: 3.28 (-0.03)

Overlook This High-Yield Dividend Industry and You Might Regret It
Sean Williams, The Motley Fool - Motley Fool - Sat Dec 13, 7:12AM CST
Source: Flickr user TaxCredits.net.  Although the stock market is two months removed from what was its largest swoon in years, the brief increase in volatility in October served two key purposes. It reminded investors that the stock market...
NLY: 11.21 (-0.05), CIM: 3.28 (-0.03), ARR: 3.69 (-0.01)

Russell 1000 Dividend Dogs: 3% Advantage For Lowest Price High Yielders In December
Fredrik Arnold - at Seeking Alpha - Thu Dec 11, 5:41PM CST

STWD: 23.42 (-0.21), NLY: 11.21 (-0.05), MFA: 8.09 (-0.03), CIM: 3.28 (-0.03), TWO: 10.28 (-0.08), AGNC: 22.14 (-0.08), CLF: 6.06 (-0.09), ARCP: 8.33 (unch), WIN: 8.74 (-0.01), NRF: 17.54 (-0.15)

7 Russell 1000 Dividend Dogs Nip 19% To 49% December Upsides
Fredrik Arnold - at Seeking Alpha - Thu Dec 11, 5:22PM CST

SEAS: 17.40 (-0.18), FCX: 22.91 (+0.07), AGNC: 22.14 (-0.08), OUT: 27.16 (+0.19), CLF: 6.06 (-0.09), RRD: 16.84 (+0.07), SDRL: 11.90 (+0.04), WIN: 8.74 (-0.01), GLPI: 29.54 (-0.07), STWD: 23.42 (-0.21), IMS: 26.30 (-0.03), MFA: 8.09 (-0.03), CIM: 3.28 (-0.03), TWO: 10.28 (-0.08), ARCP: 8.33 (unch), NRF: 17.54 (-0.15)

Equities Updates on Mortgage REITs Industry -- Chimera Investment, Annaly Capital Management, Starwood Property Trust, MFA Financial, and New Residential Investment
PR Newswire - Tue Dec 09, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: Chimera Investment Corporation (NYSE: CIM), Annaly Capital Management Inc. (NYSE: NLY), Starwood Property Trust Inc. (NYSE: STWD), MFA Financial Inc. (NYSE: MFA), and New Residential Investment Corporation (NYSE: NYZ). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Monday, December 08, 2014, ended on a negative note as the Dow Jones Industrial Average finished at 17,852.48, down 0.59% and the NASDAQ Composite closed at 4,740.69, down 0.84%. The S&P 500 finished the session 0.73% lower at 2,060.31. During the trading session, six out of ten sectors finished on a lower note. The S&P 500 Financials Sector Index ended the day at 335.07, up 0.38%, with the index advancing 6.26% in the previous three months. Register for your complimentary reports on these five stocks at:
STWD: 23.42 (-0.21), NLY: 11.21 (-0.05), MFA: 8.09 (-0.03), CIM: 3.28 (-0.03)

Assessing Rewards And Risks Of Mortgage REITs
John Dowdee - at Seeking Alpha - Mon Dec 08, 1:10AM CST

NLY: 11.21 (-0.05), CIM: 3.28 (-0.03), TWO: 10.28 (-0.08), REM: 11.75 (-0.65), AGNC: 22.14 (-0.08), HTS: 18.38 (-0.26), VNQ: 81.71 (-0.34), CMO: 12.68 (-0.12)

Mortgage REITs slip as rate expectations ratchet higher
Seeking Alpha - at Seeking Alpha - Fri Dec 05, 9:12AM CST

NLY: 11.21 (-0.05), MFA: 8.09 (-0.03), CIM: 3.28 (-0.03), MORT: 24.61 (-0.22), ARR: 3.69 (-0.01), REM: 11.75 (-0.65), AGNC: 22.14 (-0.08), WMC: 14.85 (-0.79), MORL: 21.08 (-0.33)

Danger Lurking in Chimera Investment Dividend Payout Ratio Analysis?
Anders Bylund, The Motley Fool - Motley Fool - Tue Dec 02, 5:14PM CST
Real estate investment firm Chimera Investment Corporation (NYSE: CIM) offers one of the richest dividend yields on the market today. Among 1,200 mid-cap or larger dividend payers, Chimera's 10.8% yield sits among the 20 most...
CIM: 3.28 (-0.03)

5 Russell 1000 Dogs Seize 15.7% To 43.4% November Upsides
Fredrik Arnold - at Seeking Alpha - Mon Nov 17, 2:38PM CST

AGNC: 22.14 (-0.08), CLF: 6.06 (-0.09), RRD: 16.84 (+0.07), SDRL: 11.90 (+0.04), WIN: 8.74 (-0.01), STWD: 23.42 (-0.21), SLM: 10.30 (+0.06), IMS: 26.30 (-0.03), MFA: 8.09 (-0.03), CIM: 3.28 (-0.03), CXW: 37.94 (+0.05), TWO: 10.28 (-0.08), OHI: 39.38 (-0.05), SIX: 42.72 (+0.16), ARCP: 8.33 (unch), NRF: 17.54 (-0.15)

Why Investors Should Consider Chimera Investment Corporation's Huge 11% Dividend Yield
Kingkarn Amjaroen, The Motley Fool - Motley Fool - Sat Nov 15, 7:43AM CST
Chimera Investment   offer investors more than a high dividend yield: The mortgage real estate investment trust in 2014 reversed its trend of  falling book value , has a comparatively stable dividend, and reported strong third-quarter numbers in...
NLY: 11.21 (-0.05), CIM: 3.28 (-0.03), AGNC: 22.14 (-0.08)

Chimera Is One Hell Of An mREIT This Year
Christopher F. Davis - at Seeking Alpha - Wed Nov 12, 2:15PM CST

CIM: 3.28 (-0.03)

Chimera Investment's (CIM) CEO Matt Lambiase on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 12, 1:38PM CST

CIM: 3.28 (-0.03)

13 Stocks With Dividend Yields Over 10%
Dividend Yield - at Seeking Alpha - Wed Nov 12, 9:28AM CST
I know you like dividends and can't wait to receive the next payment from your favorite company. Dividends are great, but most of the dividend stocks don't give you high amounts of cash into your pocket. Why don't we look for stocks with very high...
DCT: 35.96 (+0.21), NLY: 11.21 (-0.05), LNCO: 10.87 (-0.44), CIM: 3.28 (-0.03), TWO: 10.28 (-0.08), AGNC: 22.14 (-0.08), BBEP: 7.06 (-0.23), NTI: 22.36 (-0.21), ARCP: 8.33 (unch), LINE: 10.93 (-0.32), WIN: 8.74 (-0.01), PSEC: 8.59 (-0.02), VNR: 16.87 (-0.19)

After Yesterday's Rally of 2.54% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Nov 11, 4:54PM CST
Chimera Investment (AMEX:CIM) traded in a range yesterday that spanned from a low of $3.16 to a high of $3.24. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $3.16 on volume of 11.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CIM: 3.28 (-0.03)

Look for Shares of Chimera Investment to Potentially Pullback after Yesterday's 2.54% Rise
Comtex SmarTrend(R) - Tue Nov 11, 4:53PM CST
Chimera Investment (AMEX:CIM) traded in a range yesterday that spanned from a low of $3.16 to a high of $3.24. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $3.16 on volume of 11.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CIM: 3.28 (-0.03)

Chimera Investment (CIM) Stock Climbs Today Following Earnings Beat
at The Street - Tue Nov 11, 10:46AM CST
Chimera Investment (CIM) shares are up after the company beat analysts earnings expectations for the third quarter.
CIM: 3.28 (-0.03)

CORRECTING and REPLACING Chimera Investment Corporation Reports EPS for the 3rd Quarter 2014 of $0.37 Per Share, Core Earnings of $0.11 Per Share and Book Value of $3.50 Per Share
Business Wire - Mon Nov 10, 4:16PM CST
Headline of release should read: Chimera Investment Corporation Reports EPS for the 3rd Quarter 2014 of $0.37 Per Share, Core Earnings of $0.11 Per Share and Book Value of $3.50 Per Share (Instead of Core Earnings of $0.12 Per Share)
CIM: 3.28 (-0.03)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

CASEKOO's Montana Story Makes Brand Purpose Personal

Updated Category News Views 45

A blurry Montana kitchen, not a glossy product render, is doing the heavy lifting for CASEKOO this Thanksgiving. That is either a smart bit of brand discipline or a sentimental detour, depending on whether the company can make people feel something without losing sight of why they bought a phone case in the first place. Warmth Takes the Place of Hardware CASEKOO's new...

Continue Reading
Epiroc Takes Live Remote Drilling to CES 2027 Stage

Updated Category News Views 48

A drill rig chewing through Virginia rock from a Las Vegas convention booth is either a serious industrial-tech moment or an expensive magic trick. At CES 2027, Epiroc intends to make the distinction painfully clear. From January 6 through 9, the Stockholm-based mining-equipment company and Luck Stone will connect Booth 7031 in the LVCC West Hall to a working quarry in...

Continue Reading
Fire-Resistant Lubricants Offer a Quiet Value Shift

Updated Category News Views 67

Hydraulic fluid is not the sort of product that gets anyone pounding the table, and that is precisely why this little industrial pocket deserves a hard look. The fire-resistant lubricants market is estimated at $2.35 billion in 2026 and projected to reach $2.83 billion by 2031, implying a 3.74% compound annual growth rate. That is not a rocket ship. It is a slow-moving,...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 53

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Foresight Solar Insurance Trial Beats Fixed PPA Route

Updated Category News Views 107

Six solar sites and one settled insurance contract have produced a result worth studying, not celebrating with confetti. Foresight and Paratus say their completed renewable-price insurance policy generated a £14.49/MWh net uplift, after premium, against the revenue those assets would have earned under a fixed-price power purchase agreement. In a UK renewables market...

Continue Reading
CITGO Sign Return Caps Kenmore's Careful Rebuild Work

Updated Category News Views 62

Thirty feet upward and 120 feet eastward is not the sort of move that usually stops a city in its tracks, yet Boston’s CITGO Sign was never merely rooftop hardware. Its public relighting in Kenmore Square marks the final phase of the redevelopment at 660 Beacon Street, and the real accomplishment is less flashy than the lights: a beloved, federally landmarked object...

Continue Reading
COFE+ Barista Test Puts Robotic Coffee on the Clock

Updated Category News Views 84

A swan latte taking 18 seconds less is not nothing, even if it is hardly a verdict on the future of coffee. COFE+, the seventh-generation robotic barista from Shanghai Hi-Dolphin Robot Technology, beat an award-winning human barista across five drinks at a live November 14 competition in Yiwu. That is a clean, visible demonstration of what machines are increasingly built...

Continue Reading
Automus and Google Cloud Put Agents to Work on Oracle

Updated Category News Views 96

Oracle back offices are where shiny AI promises go to earn their keep, or get buried under a mountain of integrations. Automus Consulting’s newly announced collaboration with Google Cloud, unveiled November 20 at Oracle AI World, is aimed squarely at that messy middle. The firm wants to combine its Oracle implementation experience with Google Cloud infrastructure and...

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 76

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 35

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading

Top 5 Most Recently Viewed Articles

Synetos Aerospace Partners with AFWERX for AI Flight System

Updated Category News Views 202

Synetos Aerospace made waves back when it teamed up with AFWERX to develop an AI-enabled flight augmentation system aimed at improving the safety and efficiency of uncrewed aircraft. This partnership was not just about spiffing up tech; it showcased a commitment to enhancing operational productivity while lightening the load for operators in the increasingly fast-paced...

Continue Reading
Haruhiko Kuroda Takes on New Role at Economic Research Center

Updated Category News Views 256

Haruhiko Kuroda's New Chapter in Economic Research Former Bank of Japan Governor Haruhiko Kuroda is set to begin an exciting new role as an adviser at the Japan Center for Economic Research starting in January. This significant change comes on the heels of his long and impactful tenure at the Bank of Japan, where he served for a decade, shaping the nation's monetary...

Continue Reading
APA Corporation Discusses Key Insights for Q3 2025 Results

Updated Category News Views 269

Insights into APA Corporation's Third-Quarter 2025 APA Corporation (NASDAQ: APA) has shared important details about its projected financial and operational outcomes for the third quarter of 2025. This information aims to guide investors and analysts in their own assessments, focusing on factors expected to influence the company's performance. Estimated Average Realized...

Continue Reading
FibroGen's Strategic Move with AstraZeneca Approved Sale

Updated Category News Views 145

FibroGen Secures Approval for Strategic Sale FibroGen, Inc. (NASDAQ: FGEN), based in San Francisco, has officially received approval from the China State Administration for Market Regulation for the sale of FibroGen International (Hong Kong) Ltd. to AstraZeneca Treasury Limited. This key decision marks a significant milestone as the company moves forward with its plans...

Continue Reading
Curaleaf Secures $100 Million Credit Deal to Boost Growth

Updated Category News Views 146

Curaleaf Expands Credit Facilities to Fuel Business Growth Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF), a prominent player in the cannabis sector, has made headlines by upscaling its revolving credit facility to a whopping $100 million with Needham Bank. This move marks a pivotal moment in the cannabis financing landscape. A Landmark Financing Achievement Boris...

Continue Reading